Pierre Gholam MD

@livermd.bsky.social

6 years ago

@AASLDtweets dr. Llovet: beta catenin activation may promote resistance to #HCC IO therapies like #opdivo #keytruda and #tecentriq more data needed to confirm this #LiverMtg2019

Pierre Gholam MD

@livermd.bsky.social

6 years ago

@AASLDtweets the problem with all #NASH studies related to bariatric surgery is that you start out with 891 and end up with 66... #livermtg2019

Pierre Gholam MD

@livermd.bsky.social

6 years ago

in typical topline press release fashion, info is scarce but the mere fact that #terlipressin met primary endpoint is exciting. Plans to file NDA in Q1 2020. More data #livermtg2019